These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 35718005)

  • 1. Psychedelics as preventive treatment in headache and chronic pain disorders.
    Schindler EAD
    Neuropharmacology; 2022 Sep; 215():109166. PubMed ID: 35718005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychedelics in the Treatment of Headache and Chronic Pain Disorders.
    Schindler EAD
    Curr Top Behav Neurosci; 2022; 56():261-285. PubMed ID: 35546382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Potential of Psychedelics for the Treatment of Episodic Migraine.
    Schindler EAD
    Curr Pain Headache Rep; 2023 Sep; 27(9):489-495. PubMed ID: 37540398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adapting psychedelic medicine for headache and chronic pain disorders.
    Schindler EAD; Hendricks PS
    Expert Rev Neurother; 2023; 23(10):867-882. PubMed ID: 37652000
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are psychedelics the answer to chronic pain: A review of current literature.
    Kooijman NI; Willegers T; Reuser A; Mulleners WM; Kramers C; Vissers KCP; van der Wal SEI
    Pain Pract; 2023 Apr; 23(4):447-458. PubMed ID: 36597700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beating pain with psychedelics: Matter over mind?
    Elman I; Pustilnik A; Borsook D
    Neurosci Biobehav Rev; 2022 Mar; 134():104482. PubMed ID: 34922987
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.
    Zia FZ; Baumann MH; Belouin SJ; Dworkin RH; Ghauri MH; Hendricks PS; Henningfield JE; Lanier RK; Ross S; Berger A
    Neuropharmacology; 2023 Aug; 233():109528. PubMed ID: 37015315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knowledge, Perceptions, and Use of Psychedelics among Individuals with Fibromyalgia.
    Glynos NG; Pierce J; Davis AK; McAfee J; Boehnke KF
    J Psychoactive Drugs; 2023; 55(1):73-84. PubMed ID: 35001856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Therapeutic Potential of Psilocybin.
    Lowe H; Toyang N; Steele B; Valentine H; Grant J; Ali A; Ngwa W; Gordon L
    Molecules; 2021 May; 26(10):. PubMed ID: 34063505
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.
    Wulff AB; Nichols CD; Thompson SM
    Neuropharmacology; 2023 Jun; 231():109504. PubMed ID: 36921889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.
    Pearson C; Siegel J; Gold JA
    J Neurol Sci; 2022 Mar; 434():120096. PubMed ID: 34942586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microdosing psilocybin for chronic pain: a case series.
    Lyes M; Yang KH; Castellanos J; Furnish T
    Pain; 2023 Apr; 164(4):698-702. PubMed ID: 36066961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain.
    Van Der Walt J; Parker R
    S Afr Med J; 2023 Nov; 113(11):22-26. PubMed ID: 38525640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.
    Dworkin RH; Anderson BT; Andrews N; Edwards RR; Grob CS; Ross S; Satterthwaite TD; Strain EC
    J Pain; 2022 Oct; 23(10):1666-1679. PubMed ID: 35643270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sustained effects of single doses of classical psychedelics in humans.
    Knudsen GM
    Neuropsychopharmacology; 2023 Jan; 48(1):145-150. PubMed ID: 35729252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous psilocybin attenuates mechanical hypersensitivity in a rat model of chronic pain.
    Kolbman N; Liu T; Guzzo P; Gilligan J; Mashour GA; Vanini G; Pal D
    Curr Biol; 2023 Dec; 33(24):R1282-R1283. PubMed ID: 38113836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The varieties of psychedelic law.
    Marks M
    Neuropharmacology; 2023 Mar; 226():109399. PubMed ID: 36565855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psilocybin--summary of knowledge and new perspectives.
    Tylš F; Páleníček T; Horáček J
    Eur Neuropsychopharmacol; 2014 Mar; 24(3):342-56. PubMed ID: 24444771
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploratory Controlled Study of the Migraine-Suppressing Effects of Psilocybin.
    Schindler EAD; Sewell RA; Gottschalk CH; Luddy C; Flynn LT; Lindsey H; Pittman BP; Cozzi NV; D'Souza DC
    Neurotherapeutics; 2021 Jan; 18(1):534-543. PubMed ID: 33184743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.
    Johnson MW
    Curr Top Behav Neurosci; 2022; 56():213-227. PubMed ID: 35704271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.